Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

Flow-Tolerant Adhesion of a Bacterial Pathogen to Human Endothelial Cells Through Interaction With Biglycan.

Salo J, Pietikäinen A, Söderström M, Auvinen K, Salmi M, Ebady R, Moriarty TJ, Viljanen MK, Hytönen J.

J Infect Dis. 2016 May 15;213(10):1623-31. doi: 10.1093/infdis/jiw003. Epub 2016 Jan 5.

PMID:
26740275
2.

Decorin binding proteins of Borrelia burgdorferi promote arthritis development and joint specific post-treatment DNA persistence in mice.

Salo J, Jaatinen A, Söderström M, Viljanen MK, Hytönen J.

PLoS One. 2015 Mar 27;10(3):e0121512. doi: 10.1371/journal.pone.0121512. eCollection 2015.

3.

Specific antibody deficiency in children with recurrent respiratory infections: a controlled study with follow-up.

Ruuskanen O, Nurkka A, Helminen M, Viljanen MK, Käyhty H, Kainulainen L.

Clin Exp Immunol. 2013 May;172(2):238-44. doi: 10.1111/cei.12053.

4.

Decorin binding by DbpA and B of Borrelia garinii, Borrelia afzelii, and Borrelia burgdorferi sensu Stricto.

Salo J, Loimaranta V, Lahdenne P, Viljanen MK, Hytönen J.

J Infect Dis. 2011 Jul 1;204(1):65-73. doi: 10.1093/infdis/jir207.

5.

Extremely high prevalence of multidrug resistant tuberculosis in Murmansk, Russia: a population-based study.

Mäkinen J, Marjamäki M, Haanperä-Heikkinen M, Marttila H, Endourova LB, Presnova SE, Mathys V, Bifani P, Ruohonen R, Viljanen MK, Soini H.

Eur J Clin Microbiol Infect Dis. 2011 Sep;30(9):1119-26. doi: 10.1007/s10096-011-1200-7. Epub 2011 Mar 11.

PMID:
21394425
6.

Persistence of borrelial DNA in the joints of Borrelia burgdorferi-infected mice after ceftriaxone treatment.

Yrjänäinen H, Hytönen J, Hartiala P, Oksi J, Viljanen MK.

APMIS. 2010 Sep 1;118(9):665-73. doi: 10.1111/j.1600-0463.2010.02615.x.

PMID:
20718718
7.

TLR2 utilization of Borrelia does not induce p38- and IFN-beta autocrine loop-dependent expression of CD38, resulting in poor migration and weak IL-12 secretion of dendritic cells.

Hartiala P, Hytönen J, Yrjänäinen H, Honkinen M, Terho P, Söderström M, Penttinen MA, Viljanen MK.

J Immunol. 2010 May 15;184(10):5732-42. doi: 10.4049/jimmunol.0803944. Epub 2010 Apr 14.

8.

Disordered lymphoid purine metabolism contributes to the pathogenesis of persistent Borrelia garinii infection in mice.

Yegutkin GG, Hytönen J, Samburski SS, Yrjänäinen H, Jalkanen S, Viljanen MK.

J Immunol. 2010 May 1;184(9):5112-20. doi: 10.4049/jimmunol.0902760. Epub 2010 Mar 31.

9.

Antibacterial effects and dissolution behavior of six bioactive glasses.

Zhang D, Leppäranta O, Munukka E, Ylänen H, Viljanen MK, Eerola E, Hupa M, Hupa L.

J Biomed Mater Res A. 2010 May;93(2):475-83. doi: 10.1002/jbm.a.32564.

PMID:
19582832
10.

Bordetella pertussis isolates in Finland: serotype and fimbrial expression.

Heikkinen E, Xing DK, Olander RM, Hytönen J, Viljanen MK, Mertsola J, He Q.

BMC Microbiol. 2008 Sep 25;8:162. doi: 10.1186/1471-2180-8-162.

11.

Borreliosis: recent research, diagnosis, and management.

Hytönen J, Hartiala P, Oksi J, Viljanen MK.

Scand J Rheumatol. 2008 May-Jun;37(3):161-72. doi: 10.1080/03009740801978897. Review.

PMID:
18465449
12.

Borrelia burgdorferi inhibits human neutrophil functions.

Hartiala P, Hytönen J, Suhonen J, Leppäranta O, Tuominen-Gustafsson H, Viljanen MK.

Microbes Infect. 2008 Jan;10(1):60-8. Epub 2007 Oct 18.

PMID:
18068388
13.

Antibacterial effect of bioactive glasses on clinically important anaerobic bacteria in vitro.

Leppäranta O, Vaahtio M, Peltola T, Zhang D, Hupa L, Hupa M, Ylänen H, Salonen JI, Viljanen MK, Eerola E.

J Mater Sci Mater Med. 2008 Feb;19(2):547-51. Epub 2007 Jul 10.

PMID:
17619981
14.

Bactericidal effects of bioactive glasses on clinically important aerobic bacteria.

Munukka E, Leppäranta O, Korkeamäki M, Vaahtio M, Peltola T, Zhang D, Hupa L, Ylänen H, Salonen JI, Viljanen MK, Eerola E.

J Mater Sci Mater Med. 2008 Jan;19(1):27-32. Epub 2007 Jun 14.

PMID:
17569007
15.

Transcriptional response of human dendritic cells to Borrelia garinii--defective CD38 and CCR7 expression detected.

Hartiala P, Hytönen J, Pelkonen J, Kimppa K, West A, Penttinen MA, Suhonen J, Lahesmaa R, Viljanen MK.

J Leukoc Biol. 2007 Jul;82(1):33-43. Epub 2007 Apr 17.

PMID:
17440035
16.

Anti-tumor necrosis factor-alpha treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice.

Yrjänäinen H, Hytönen J, Song XY, Oksi J, Hartiala K, Viljanen MK.

J Infect Dis. 2007 May 15;195(10):1489-96. Epub 2007 Apr 6.

PMID:
17436229
17.

Use of CFSE staining of borreliae in studies on the interaction between borreliae and human neutrophils.

Tuominen-Gustafsson H, Penttinen M, Hytönen J, Viljanen MK.

BMC Microbiol. 2006 Oct 18;6:92.

18.

Bordetella holmesii DNA is not detected in nasopharyngeal swabs from Finnish and Dutch patients with suspected pertussis.

Antila M, He Q, de Jong C, Aarts I, Verbakel H, Bruisten S, Keller S, Haanperä M, Mäkinen J, Eerola E, Viljanen MK, Mertsola J, van der Zee A.

J Med Microbiol. 2006 Aug;55(Pt 8):1043-51.

PMID:
16849724
19.

Persistent joint swelling and Borrelia-specific antibodies in Borrelia garinii-infected mice after eradication of vegetative spirochetes with antibiotic treatment.

Yrjänäinen H, Hytönen J, Söderström KO, Oksi J, Hartiala K, Viljanen MK.

Microbes Infect. 2006 Jul;8(8):2044-51. Epub 2006 May 30.

PMID:
16797205
20.

Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis.

Mäkinen J, Marttila HJ, Marjamäki M, Viljanen MK, Soini H.

J Clin Microbiol. 2006 Feb;44(2):350-2.

21.

Quantification of bacteria in human feces using 16S rRNA-hybridization, DNA-staining and flow cytometry.

Vaahtovuo J, Korkeamäki M, Munukka E, Viljanen MK, Toivanen P.

J Microbiol Methods. 2005 Dec;63(3):276-86. Epub 2005 Jun 1.

PMID:
15935498
22.

No evidence of cross-reactivity of human antibodies to a 33-mer peptide of the alpha-gliadin component of gluten with Bordetella pertussis pertactin.

He Q, Viljanen MK, Hinkkanen AE, Arvilommi H, Mertsola J, Viander M.

Vaccine. 2005 May 9;23(25):3336-40.

PMID:
15837240
23.

Bordetella pertussis isolates, Finland.

Mäkinen J, Mertsola J, Mooi FR, Van Amersfoorth S, Arvilommi H, Viljanen MK, He Q.

Emerg Infect Dis. 2005 Jan;11(1):183-4. No abstract available.

24.

[What does the genome sequence of tuberculosis bacteria reveal to us?].

Viljanen MK.

Duodecim. 2004;120(18):2230-1. Review. Finnish. No abstract available.

PMID:
15560459
25.

Prospective evaluation of the GenoType assay for routine identification of mycobacteria.

Sarkola A, Mäkinen J, Marjamäki M, Marttila HJ, Viljanen MK, Soini H.

Eur J Clin Microbiol Infect Dis. 2004 Aug;23(8):642-5. Epub 2004 Jul 28.

PMID:
15322939
26.

Application of Bacillus anthracis PCR to simulated clinical samples.

Rantakokko-Jalava K, Viljanen MK.

Clin Microbiol Infect. 2003 Oct;9(10):1051-6.

27.

PFGE and pertactin gene sequencing suggest limited genetic variability within the Finnish Bordetella parapertussis population.

Mäkinen J, Mertsola J, Soini H, Arvilommi H, Viljanen MK, Guiso N, He Q.

J Med Microbiol. 2003 Dec;52(Pt 12):1059-63.

PMID:
14614063
28.

Performance of BACTEC 960 Mycobacteria growth indicator tube in the susceptibility testing of genetically characterized Mycobacterium tuberculosis isolates.

Marttila HJ, Marjamäki M, Viljanen MK, Soini H.

Eur J Clin Microbiol Infect Dis. 2003 Dec;22(12):757-9. Epub 2003 Nov 6.

PMID:
14605940
29.

Semiquantitative detection by real-time PCR of Aspergillus fumigatus in bronchoalveolar lavage fluids and tissue biopsy specimens from patients with invasive aspergillosis.

Rantakokko-Jalava K, Laaksonen S, Issakainen J, Vauras J, Nikoskelainen J, Viljanen MK, Salonen J.

J Clin Microbiol. 2003 Sep;41(9):4304-11.

30.

Interaction between Borrelia burgdorferi and immature human dendritic cells.

Suhonen J, Komi J, Soukka J, Lassila O, Viljanen MK.

Scand J Immunol. 2003 Jul;58(1):67-75.

31.

[Newest tricks how to fool the immune system].

Viljanen MK.

Duodecim. 2003;119(8):801-9. Finnish. No abstract available.

PMID:
12806744
32.

Prevalence of granulocytic Ehrlichia and Borrelia burgdorferi sensu lato in Ixodes ricinus ticks collected from Southwestern Finland and from Vormsi Island in Estonia.

Mäkinen J, Vuorinen I, Oksi J, Peltomaa M, He Q, Marjamäki M, Viljanen MK.

APMIS. 2003 Feb;111(2):355-62.

PMID:
12716393
33.

Characterization of Finnish Mycobacterium tuberculosis isolates by spoligotyping.

Puustinen K, Marjamäki M, Rastogi N, Sola C, Filliol I, Ruutu P, Holmström P, Viljanen MK, Soini H.

J Clin Microbiol. 2003 Apr;41(4):1525-8.

34.

Bordetella pertussis protein pertactin induces type-specific antibodies: one possible explanation for the emergence of antigenic variants?

He Q, Mäkinen J, Berbers G, Mooi FR, Viljanen MK, Arvilommi H, Mertsola J.

J Infect Dis. 2003 Apr 15;187(8):1200-5. Epub 2003 Mar 26.

PMID:
12695998
35.

Sublethal concentrations of complement can effectively opsonize Borrelia burgdorferi.

Suhonen J, Hartiala K, Tuominen-Gustafsson H, Viljanen MK.

Scand J Immunol. 2002 Dec;56(6):554-60.

36.

Early impairment of coronary flow reserve is not associated with Chlamydia pneumoniae antibodies.

Janatuinen T, Friberg J, Viljanen MK, Raitakari OT, Nuutila P, Vainionpää R, Oksi J, Peltonen R, Engblom E, Laine H, Knuuti J.

Ann Med. 2002;34(4):284-90.

PMID:
12375580
37.

Evaluation of genotype and LiPA MYCOBACTERIA assays for identification of Finnish mycobacterial isolates.

Mäkinen J, Sarkola A, Marjamäki M, Viljanen MK, Soini H.

J Clin Microbiol. 2002 Sep;40(9):3478-81.

39.

Early dissemination of Borrelia burgdorferi without generalized symptoms in patients with erythema migrans.

Oksi J, Marttila H, Soini H, Aho H, Uksila J, Viljanen MK.

APMIS. 2001 Sep;109(9):581-8.

PMID:
11878710
41.

LCx Mycobacterium tuberculosis assay is valuable with respiratory specimens, but provides little help in the diagnosis of extrapulmonary tuberculosis.

Rantakokko-Jalava K, Marjamäki M, Marttila H, Mäkelä L, Valtonen V, Viljanen MK.

Ann Med. 2001 Feb;33(1):55-62.

PMID:
11310940
42.

Erythema migrans--influence of posture. Case report.

Oksi J, Hietarinta M, Viljanen MK.

APMIS. 2000 Oct;108(10):649-51.

PMID:
11200819
44.
45.

The expanding clinical spectrum of ocular lyme borreliosis.

Mikkilä HO, Seppälä IJ, Viljanen MK, Peltomaa MP, Karma A.

Ophthalmology. 2000 Mar;107(3):581-7.

PMID:
10711899
46.

Immune responses to pertussis antigens eight years after booster immunization with acellular vaccines in adults.

Tran Minh NN, He Q, Edelman K, Putto-Laurila A, Arvilommi H, Viljanen MK, Mertsola J.

Vaccine. 2000 Apr 3;18(19):1971-4.

PMID:
10706957
47.

Borrelia burgdorferi--induced oxidative burst, calcium mobilization, and phagocytosis of human neutrophils are complement dependent.

Suhonen J, Hartiala K, Tuominen-Gustafsson H, Viljanen MK.

J Infect Dis. 2000 Jan;181(1):195-202.

PMID:
10608767
48.

Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents.

Tran Minh NN, He Q, Ramalho A, Kaufhold A, Viljanen MK, Arvilommi H, Mertsola J.

Pediatrics. 1999 Dec;104(6):e70.

PMID:
10586004
49.

Line probe assay in the rapid detection of rifampin-resistant Mycobacterium tuberculosis directly from clinical specimens.

Marttila HJ, Soini H, Vyshnevskaya E, Vyshnevskiy BI, Otten TF, Vasilyef AV, Viljanen MK.

Scand J Infect Dis. 1999;31(3):269-73.

PMID:
10482056
50.

Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis.

Oksi J, Marjamäki M, Nikoskelainen J, Viljanen MK.

Ann Med. 1999 Jun;31(3):225-32.

PMID:
10442678

Supplemental Content

Loading ...
Support Center